Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

APIXABAN for Pulmonary embolism: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 5,234 adverse event reports in the FDA FAERS database where APIXABAN was used for Pulmonary embolism.

Most Reported Side Effects for APIXABAN

Side Effect Reports % Deaths Hosp.
Death 18,501 11.6% 18,461 627
Cerebrovascular accident 7,237 4.5% 458 1,688
Atrial fibrillation 5,690 3.6% 202 2,112
Off label use 5,590 3.5% 491 1,869
Thrombosis 5,298 3.3% 168 1,444
Fall 5,063 3.2% 687 2,620
Cardiac disorder 4,917 3.1% 197 1,184
Haemorrhage 4,770 3.0% 370 1,567
Dyspnoea 4,379 2.7% 233 2,135
Gastrointestinal haemorrhage 4,030 2.5% 508 2,340
Adverse event 3,871 2.4% 46 620
Dizziness 3,608 2.3% 35 1,087
Fatigue 3,403 2.1% 89 1,160
Hospitalisation 3,315 2.1% 89 3,287
Anaemia 3,243 2.0% 254 2,394

Other Indications for APIXABAN

Product used for unknown indication (88,417) Cerebrovascular accident prophylaxis (36,113) Atrial fibrillation (10,500) Deep vein thrombosis (6,535) Thrombosis prophylaxis (4,304) Embolism venous (2,443) Anticoagulant therapy (1,275) Thrombosis (1,201) Cerebrovascular accident (448) Prophylaxis (332)

Other Drugs Used for Pulmonary embolism

RIVAROXABAN (11,707) WARFARIN (1,552) ENOXAPARIN (1,155) HEPARIN (786) ALTEPLASE (617) DABIGATRAN ETEXILATE (527) DALTEPARIN (431) EDOXABAN (307) XARELTO (284) ASPIRIN (192)

Related Pages

APIXABAN Full Profile All Pulmonary embolism Drugs APIXABAN Demographics APIXABAN Timeline